Language selection

Search

Patent 2576457 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent Application: (11) CA 2576457
(54) English Title: CONTAINER SYSTEM
(54) French Title: SYSTEME DE CONTENANT
Status: Deemed Abandoned and Beyond the Period of Reinstatement - Pending Response to Notice of Disregarded Communication
Bibliographic Data
(51) International Patent Classification (IPC):
  • B65D 1/08 (2006.01)
  • B65D 47/18 (2006.01)
(72) Inventors :
  • GERONDALE, SCOTT J. (United States of America)
  • SPADA, LON T. (United States of America)
  • BUTORAC, PAUL T. (United States of America)
(73) Owners :
  • ALLERGAN, INC.
(71) Applicants :
  • ALLERGAN, INC. (United States of America)
(74) Agent: GOWLING WLG (CANADA) LLP
(74) Associate agent:
(45) Issued:
(86) PCT Filing Date: 2005-08-05
(87) Open to Public Inspection: 2006-02-23
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): Yes
(86) PCT Filing Number: PCT/US2005/027872
(87) International Publication Number: US2005027872
(85) National Entry: 2007-02-07

(30) Application Priority Data:
Application No. Country/Territory Date
10/916,067 (United States of America) 2004-08-11

Abstracts

English Abstract


A container system includes a squeeze bottle (10) of a specific volume having
a neck (14) with an open end (16) and a medicament disposed within the bottle.
A tip (40) is provided which is insertable into the open end of the squeezable
bottle and includes an internal tapered nozzle with the nozzle (46) having
increased diameter toward a tip opening (50). A cap (80) is provided for
removable attachment to the bottleneck for sealing the tip opening and a
shoulder (50) formed in the bottle proximate the neck and disposed at an angle
is provided in order to enhance bubbless flow of the medicament to the nozzle
and facilitate tamper proof sealing of the cap.


French Abstract

La présente invention a trait à un système de contenant comportant un flacon pressable (10) de volume déterminé présentant un goulot (14) avec une extrémité ouverte (16) et un médicament disposé dans le flacon. Un embout (40) est prévu qui est insérable dans l'extrémité ouverte du flacon pressable et comporte une buse interne effilée, la buse (46) ayant un diamètre croissant vers l'ouverture de l'embout (50). Une capsule (80) est agencée pour une fixation amovible au goulot pour le scellement de l'embout et un épaulement (50) est formé dans le flacon à proximité du goulot et disposé à un angle agencé pour améliorer l'écoulement sans bulles du médicament vers la buse et faciliter le scellement inviolable de la capsule.

Claims

Note: Claims are shown in the official language in which they were submitted.


WHAT IS CLAIMED IS:
1. A container system comprising:
a squeeze bottle of a specific volume having a neck
with an open end;
a medicament disposed in the bottle;
a tip insertable into said open end and having an
internal tapered nozzle, the nozzle having increased diameter
toward a tip opening;
a cap for removable attachment to the bottle neck
for sealing said tip opening;
a shoulder formed into the bottle proximate said
neck and disposed at an angle of between about 45° and about
50° to a bottle centerline in order to enhance bubbless flow
of medicament to the nozzle and facilitate tamper proof
sealing of said cap.
2. The container system according to claim 1 further
comprises a tip face surrounding said tip opening with a face
width to control uniformity and size of medicament droplets
formed at said tip opening by squeezing of the bottle.
3. The container system according to claim 2 wherein
said face width is between about 0.015 inches and about 0.060
inches and the specific volume is between about 5 ml and about
15 ml.
4. The container system according to claim 3 wherein
the droplet size is between about 10µl and about 50µl.
9

5. A container system comprising:
a squeeze bottle of a specific volume having a neck
with an open end;
a medicament disposed in the bottle;
a tip insertable into said open end and having an
internal tapered nozzle, the nozzle having increased diameter
toward a tip opening, said tip including a face surrounding
said tip opening with a face width to control uniformity and
size of medicament droplets formed at said tip opening by
squeezing of the bottle; and
a threaded cap for removable attachment to the
bottleneck for sealing said tip opening.
6. The container system according to claim 5 wherein
said face width is between about 0.015 inches and about 0.060
inches and the specific volume is between about 5 ml about 15
ml.
7. The container system according to claim 6 wherein
the droplet size is between about 10µl and about 50µl.
8. The container system according to claim 5 further
comprising a shoulder formed into the bottle proximate said
neck and disposed at an angle of between about 45° and about
50° to a bottle centerline in order to enhance bubbless flow
of medicament to the nozzle and facilitate tamper proof
sealing of said cap to said neck.

Description

Note: Descriptions are shown in the official language in which they were submitted.


CA 02576457 2007-02-07
WO 2006/020509 PCT/US2005/027872
3241
CONTAINER SYSTEM
The present invention generally relates to dropper
bottles for dispensing of medicaments in droplet form and is
more particularly directed to a container system for
dispensing medicaments in less than 100 ml volumes with
precise and uniform droplets.
Heretofore, dropwise container systems have typically
included nozzles that are press fitted or otherwise inserted
into a neck portion of a squeeze bottle.
In operation, squeeze bottle is inverted and manually
squeezed by a user to dispense one or more drops through the
nozzle. When medicament delivery when the medicament is fully
dispensed, the container system is typically discarded.
Heretofore, resilient squeeze bottles often have
substantial drop-to-drop volume variation when dispensing one
or more drops in volumes of less than 100 ml, particularly in
the 10 to 50 ml range.
This variation may be due to a bubble formation on
interior surfaces of the bottle when the bottle is inverted so
that drops, particularly eye drop medicati_on, are dispensed
unevenly. Such adhered bubbles may be prevalent in square
shoulder bottles and nozzles having areas which promote such
bubble formation.
1

CA 02576457 2007-02-07
WO 2006/020509 PCT/US2005/027872
In addition, in view of the popularity of tamper proof
bottles, it is desirable to facilitate the installation of
such tamper proof systems.
Accordingly, there is a need for an improved container
system for providing a uniform dropwise dispensing of
medication.
SUMMARY OF THE INVENTION
A container system in accordance with the present
invention generally includes a squeeze bottle of a specific
volume having a neck with an open end and a medicament
disposed within the bottle.
A tip fixable to the open end and includes internal
tapered nozzle with the nozzle having increased diameter
toward a tip opening.
A cap is provided for removably sealing the tip opening
by attachment to the bottleneck.
A shoulder formed into the bottle proximate the neck and
disposed at an angle of between about 45 and about 50 to a
bottle centerline, is provided in order to both enhance
bubbless flow of medicament to the nozzle and facilitate
tamper proof sealing of the cap.
2

CA 02576457 2007-02-07
WO 2006/020509 PCT/US2005/027872
More particularly, the container system in accordance
with the present invention may include a tip face surrounding
the tip opening with a face width to control the uniformity
and size of the droplets formed at the tip opening by
squeezing of the bottle. In that regard, the face width may
be between about 0.015 inches and about 0.060 inches with the
specific volume of the bottle of between about 5 ml and about
ml.
10 Preferably, the container system in accordance with the
present invention provides droplet sizes between about 10 ml
and about 50 ml.
BRIEF DESCRIPTION OF THE DRAWINGS
The advantages and features of the present invention will
be better understood by the following description when
considered in conjunction with the accompanying drawings in
which:
Figure 1 is a side view of a 5 ml bottle in accordance
with the present invention generally showing a neck with an
open end and a shoulder formed into the bottle proximate the
neck having an angle of between about 45 and 50 to a bottle
centerline;
Figure 2 is a top view of the bottle shown in Figure 1;
3

CA 02576457 2007-02-07
WO 2006/020509 PCT/US2005/027872
Figure 3 is a cross sectional view of the bottle shown in
Figure 2 taken along the line 3-3;
Figure 4 is an enlarged view of the bottleneck shown in
Figures 1 and 3;
Figure 5 is a side view of a 10 ml bottle in accordance
with the present invention;
Figure 6 is a top view of the bottle shown in Figure 5;
Figure 7 is a cross sectional view of the bottle shown in
Figure 6 taken along the line 7-7;
Figure 8 is a side view of a 15 ml bottle in accordance
with the present invention;
Figure 9 is a top view of the bottle shown in Figure 8;
Figure 10 is a cross sectional view taken along the line
10-10 of Figure 9;
Figure 11 is a side view of a tip in accordance with the
present invention for insertion into the neck of the bottle of
the present invention;
Figure 12 is a top view of the tip shown in Figure 11;
Figure 13 is a bottom view of the tip shown in Figure 11;
4

CA 02576457 2007-02-07
WO 2006/020509 PCT/US2005/027872
Figure 14 is a cross sectional view of the tip shown in
Figure 13 taken along the line 14-14 and showing an internal
nozzle and a face surrounding a tip opening;
Figure 15 is a side view of another tip in accordance
with the present invention;
Figure 16 is a top view of the tip shown in Figure 15;
Figure 17 is a bottom view of the tip shown in Figure 15;
Figure 18 is a cross sectional view taken along the line
18-18 of Figure 17 showing a larger face surrounding a tip
opening and an internal nozzle;
Figure 19 is a side view of a cap suitable for closure of
the tips and bottles of the present invention;
Figure 20 is a top view of the cap shown in Figure 19;
Figure 21 is a bottom view of the cap shown in Figure 19;
Figure 22 is a cross sectional view of the cap taken
along the line 20-22 of Figure 21; and
Figure 23 is a side view of an assembled bottle and cap
along with a taper proof seal.
5

CA 02576457 2007-02-07
WO 2006/020509 PCT/US2005/027872
DETAILED DESCRIPTION
With reference to Figures 1-3, there is shown a squeeze
bottle 10 in accordance with the present invention having a
neck 14 with an open end 16, see also Figure 4, which is an
enlarged view of the neck 14 of the bottle 10 in accordance
with the.present invention...
The bottle 10 may be formed from a suitable material,
such as, for example, low-density polyethylene. The bottle 10
has a specific volume of 5 ml for containing a medicament 20
suitable for installation into an eye, not shown, by droplet
formation, as will be hereinafter discussed in greater detail.
Figures 5-7 illustrate a bottle 24 in accordance with the
present invention similar to that shown in Figures 1-3 with
the bottle 24 having a specific volume of 10 ml and a neck 26
with an opening 28 therein.
Figures 8-10 illustrate a bottle 32 in accordance with
the present invention which has a specific volume of 15 ml
along with a neck 34, an opening 36.
As illustrated in Figures 12-14, a tip 40 in accordance
with the present invention includes a base 42 sized for
insertion into the bottleneck opening 16 and includes an
internal tapered nozzle 46 having increased diameter toward a
tip opening 50.
6

CA 02576457 2007-02-07
WO 2006/020509 PCT/US2005/027872
With reference again to Figures 1, 3, 5, 7, 8, and 10
each of the bottles 10, 24, 32 include shoulders 50, 52, 54
proximate necks 14, 26, 34 and disposed at an angle of between
about 450 and about 500 to bottle centerlines 58, 60, 62, with
an angle of 470 in 30 seconds being shown as a specific
example.
This shoulder angle enhances bubbless flow of medicament
20 to the nozzle 46.
Figures 15-18 illustrate another nozzle 66 in accordance
with the present invention including a base 68 sized for
insertion into openings 16, 28, 34 and including an internal
nozzle 70 similar to the nozzle 46 of the tip 40.
In comparing the tip 46 and 68, it can be seen that each
include tip faces 72, 74 respectively surrounding openings 50,
80 respectively and having different surface areas, or face
widths.
In the case of tip 40, the face width is about 0.015
inches while with the tip 66 the face width is about 0.060
inches. While only two tips 40, 66 being shown, it should be
appreciated that similar tips having different tip face width
dimensions are to be considered within the scope of the
present invention and taken in combination with various bottle
sizes, such as, for example, 5 ml, 10 ml, and 15 ml
illustrated by the bottles 10, 24, 32 enable the control
dropwise dispensing of medicament 20 with droplet sizes
7

CA 02576457 2007-02-07
WO 2006/020509 PCT/US2005/027872
between less than l0p1 and about 50u1, preferably between
about 8-12 pl. A greater face area provides for a larger
droplet size.
With reference to Figures 19-22, there is shown a cap 80,
formed from a suitable material having internal threads 82 for
engaging a neck threads 84, see Figures 1 and 3 for example,
and sealing the tip opening 50 with a convex surface 88.
An assembled container system 92 is shown in Figure 23
along with a tamper proof seal 96. Importantly, the sloped
shoulder 50 facilitates the application of the seal 96 and
enables a larger surface of the bottle 10 upper surface 100 to
be sealed along with the cap 80 in order to provide a more
secure tamper proof seal 96.
Although there has been hereinabove described a specific
container system in accordance with the present invention for
the purpose of illustrating the manner in which the invention
may be used to advantage, it should be appreciated that the
invention is not limited thereto. That is, the present
invention may suitably comprise, consist of, or consist
essentially of the recited elements. Further, the invention
illustratively disclosed herein suitably may be practiced in
the absence of any element which is not specifically disclosed
herein. Accordingly, any and all modifications, variations or
equivalent arrangements which may occur to those skilled in
the art, should be considered to be within the scope of the
present invention as defined in the appended claims.
8

Representative Drawing
A single figure which represents the drawing illustrating the invention.
Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Application Not Reinstated by Deadline 2011-08-05
Time Limit for Reversal Expired 2011-08-05
Inactive: Abandon-RFE+Late fee unpaid-Correspondence sent 2010-08-05
Deemed Abandoned - Failure to Respond to Maintenance Fee Notice 2010-08-05
Appointment of Agent Requirements Determined Compliant 2007-10-11
Revocation of Agent Requirements Determined Compliant 2007-10-11
Appointment of Agent Request 2007-09-19
Revocation of Agent Request 2007-09-19
Letter Sent 2007-05-09
Inactive: Cover page published 2007-04-24
Inactive: Courtesy letter - Evidence 2007-04-17
Inactive: Notice - National entry - No RFE 2007-04-11
Inactive: Single transfer 2007-03-30
Application Received - PCT 2007-03-01
National Entry Requirements Determined Compliant 2007-02-07
Application Published (Open to Public Inspection) 2006-02-23

Abandonment History

Abandonment Date Reason Reinstatement Date
2010-08-05

Maintenance Fee

The last payment was received on 2009-07-20

Note : If the full payment has not been received on or before the date indicated, a further fee may be required which may be one of the following

  • the reinstatement fee;
  • the late payment fee; or
  • additional fee to reverse deemed expiry.

Patent fees are adjusted on the 1st of January every year. The amounts above are the current amounts if received by December 31 of the current year.
Please refer to the CIPO Patent Fees web page to see all current fee amounts.

Fee History

Fee Type Anniversary Year Due Date Paid Date
Basic national fee - standard 2007-02-07
Registration of a document 2007-02-07
MF (application, 2nd anniv.) - standard 02 2007-08-06 2007-07-18
MF (application, 3rd anniv.) - standard 03 2008-08-05 2008-07-28
MF (application, 4th anniv.) - standard 04 2009-08-05 2009-07-20
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
ALLERGAN, INC.
Past Owners on Record
LON T. SPADA
PAUL T. BUTORAC
SCOTT J. GERONDALE
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column (Temporarily unavailable). To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Claims 2007-02-06 2 69
Abstract 2007-02-06 1 62
Description 2007-02-06 8 265
Representative drawing 2007-02-06 1 4
Drawings 2007-02-06 5 128
Cover Page 2007-04-23 1 35
Reminder of maintenance fee due 2007-04-10 1 109
Notice of National Entry 2007-04-10 1 192
Courtesy - Certificate of registration (related document(s)) 2007-05-08 1 105
Reminder - Request for Examination 2010-04-06 1 121
Courtesy - Abandonment Letter (Maintenance Fee) 2010-09-29 1 172
Courtesy - Abandonment Letter (Request for Examination) 2010-11-11 1 165
PCT 2007-02-06 12 480
Correspondence 2007-04-10 1 26
Correspondence 2007-09-18 1 33
Fees 2008-07-27 1 41